Evidence map›Paper›PMID 37296184›Full record

ArticleScientific reports2023

A perfusion-based three-dimensional cell culture system to model alveolar rhabdomyosarcoma pathological features.

Mattia Saggioro, Stefania D'Agostino, Giulia Veltri, Maira Bacchiega, Lucia Tombolan, Carlo Zanon, Piergiorgio Gamba, Valentina Serafin, Manuele Giuseppe Muraro, Ivan Martin and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Mattia Saggioro *Department of Women's and Children's Health, University of Padova, 35129, Padova, Italy.
Stefania D'Agostino *Department of Women's and Children's Health, University of Padova, 35129, Padova, Italy.
Giulia VeltriOncohematology Laboratory, Institute of Pediatric Research Città della Speranza, 35127, Padova, Italy.
Maira BacchiegaDepartment of Women's and Children's Health, University of Padova, 35129, Padova, Italy.
Lucia TombolanPediatric Solid Tumors Laboratory, Fondazione Istituto di Ricerca Pediatrica Città della Speranza, 35127, Padova, Italy.
Carlo ZanonBioinformatics Core Service, Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy.
Piergiorgio GambaDepartment of Women's and Children's Health, University of Padova, 35129, Padova, Italy.
Valentina SerafinOncohematology Laboratory, Institute of Pediatric Research Città della Speranza, 35127, Padova, Italy.
Manuele Giuseppe MuraroDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031, Basel, Switzerland. michela.pozzobon@unipd.it.
Ivan MartinDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031, Basel, Switzerland.
Michela PozzobonDepartment of Women's and Children's Health, University of Padova, 35129, Padova, Italy. manuele.muraro@usb.ch.
Città della Speranza Foundation · ITUniversity of Padua · ITUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although a rare disease, rhabdomyosarcoma (RMS) is one of the most common cancers in children the more aggressive and metastatic subtype is the alveolar RMS (ARMS). Survival outcomes with metastatic disease remain dismal and the need for new models that recapitulate key pathological features, including cell-extracellular matrix (ECM) interactions, is warranted. Here, we report an organotypic model that captures cellular and molecular determinants of invasive ARMS. We cultured the ARMS cell line RH30 on a collagen sponge in a perfusion-based bioreactor (U-CUP), obtaining after 7 days a 3D construct with homogeneous cell distribution. Compared to static culture, perfusion flow induced higher cell proliferation rates (20% vs. 5%), enhanced secretion of active MMP-2, and upregulation of the Rho pathway, associated with cancer cell dissemination. Consistently, the ECM genes LAMA1 and LAMA2, the antiapoptotic gene HSP90, identified in patient databases as hallmarks of invasive ARMS, were higher under perfusion flow at mRNA and protein level. Our advanced ARMS organotypic model mimics (1) the interactions cells-ECM, (2) the cell growth maintenance, and (3) the expression of proteins that characterize tumor expansion and aggressiveness. In the future, the perfusion-based model could be used with primary patient-derived cell subtypes to create a personalized ARMS chemotherapy screening system.

Indexed as

RhabdomyosarcomaRhabdomyosarcoma, AlveolarCell Culture Techniques, Three DimensionalCell LineCell Line, TumorChildHumansPerfusion

Identifiers

PMID37296184
PMCPMC10256844
OpenAlexW4379984246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.